Medical Affairs Outsourcing
Medical Affairs Outsourcing
To request a consultation, please contact Beth Price at BPrice@TMACmail.com or 678-581-4445.
Looking for a Medical Affairs Outsourcing partner?
The Medical Affairs Company (TMAC) is a full-service Contract Medical Organization that provides the pharmaceutical, biotechnology and medical device industries with strategically sound, expertly staffed and flawlessly executed medical affairs solutions. We offer clients an impressive complement of both strategic and tactical Medical Affairs solutions, including field-based Medical Science Liaison programs and Medical Communications support.
The team has partnered with over one hundred clients across myriad therapeutic areas deploying customized MSL and Medical Communications teams who engage in the full spectrum of scientific exchange, including new approaches to disease management, new product introductions, product expansions and medically-accepted practice issues.
Medical Science Liaison Solutions
TMAC can help you define your medical affairs strategy and goals and then identify the type of team needed to achieve your goals, taking into consideration the lifecycle of your products, your corporate culture, key stakeholders and current market dynamics.
In addition, TMAC can help you form a Medical Science Liaison team from the ground up or optimize the performance of your existing team through seamlessly integrated programs that are available on an outsourced or consultative basis.
MSL Programs
- Medical Science Liaisons (MSLs)
- Clinical Trial Liaisons (CTLs)
- Managed Care/Managed Markets Liaisons (MCLs/MMLs)
- Field-based Outcomes Research Managers (FORMs)
- Clinical Specialists (CSs)
Program Architecture
- Flexible Field-based Models
- Strategic Planning
- Capacity Analysis/Territory Alignment
- SOPs/Processes
Program Management/Support
- Seasoned MSL Leaders
- Single Point of Client Contact
- Expert Recruitment & Expedient Deployment
Medical Communications
The Medical Affairs Company (TMAC) understands the importance of strategic, timely, compliant, and scientifically-sound Medical Communications. Accordingly, we offer an array of Medical Communications services designed to meet your unique needs.
Drug Information/Call Center Services
- Staffed by Experienced Healthcare Professionals
- Live 8 or 12-hour service
- IRMS Database
Pharmacovigilance
- Adverse Event Reporting
- Annual Periodic Reporting
- Product Complaints
Medical Writing & Informatics
- Standard Letters
- FAQs
- SOPs
Medical Meeting Support & Surveillance
- Scientific Booth Staffing
- Symposia/Poster Reviews
- Competitive Intelligence Analysis
Library Services
- Literature Surveillance and Analysis
- Document Retrieval
- Copyright Clearance Management
MSL Training & Reporting Systems
TMAC offers a comprehensive training curriculum and tools to monitor your medical affairs activities.
The Value of Partnering with TMAC
TMAC is unique in that we are the only Contract Medical Organization that provides the pharmaceutical industry with both turnkey deployment of MSL teams and seamless access to an array of innovative consultative solutions. No other organization can help you either create a field based medical team from the ground up or optimize the performance of an existing team.
By partnering with TMAC, you can be assured of the following:
- Scientifically robust, compliant and appropriate exchanges
- Efficient use of internal resources, enabling a constant focus on critical milestones
- Experienced and seasoned TMAC management integrated seamlessly into your organization
- Extensive database of viable MSL and medical communications candidates meeting the specific criteria of your therapeutic area/product portfolio
- Customized and flexible partnership models
- Access to reporting and knowledge management tools and resources
- Implementation of comprehensive training program including compliance modules
- Ability to strategically deploy highly credentialed MSL and medical communications teams within 8-10 weeks
- Option to internalize MSLs and program components at the end of the initial term